Clinical Trial Update: A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses [Phase 1]

View source ↗

Summary

Phase I trial update for SHR-2906 evaluating a single-dose injection in healthy subjects and multiple-dose injections in obese patients. The study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• SHR-2906 (SHR-2906)

Snippet

Sponsor: Beijing Suncadia Pharmaceuticals Co., Ltd | Conditions: Obesity, Overweight | Phase 1 | Status: NOT_YET_RECRUITING